Ensuring Quality Medicine is not a Single Event but Rather Combines Effects of a Pharmaceutical Company

Authors

  • Rashed Ahmed Department of Pharmaceutical Sciences, North South University, Bangladesh

DOI:

https://doi.org/10.56778/rjhs.v2i2.360

Keywords:

Quality Medicine, Rather Combines

Abstract

The article "Ensuring Quality Medicine is Not a Single Event but a Combined Effort of a Pharmaceutical Company" explores the multifaceted approach required to maintain high standards in pharmaceutical manufacturing. It emphasizes that quality assurance in medicine production is not an isolated event but a continuous, integrated process involving multiple departments and stages. The article highlights the roles of research and development, rigorous clinical trials, regulatory compliance, and robust manufacturing practices in ensuring the efficacy and safety of medicines. It also discusses the importance of quality control measures, such as stringent testing protocols and regular audits, to detect and mitigate potential issues early. The collaboration between different teams within a pharmaceutical company, including scientists, engineers, and quality assurance professionals, is crucial for sustaining quality throughout the product lifecycle. Moreover, the article addresses the necessity of adhering to global standards and guidelines, such as Good Manufacturing Practices (GMP), to ensure consistency and reliability in drug production. By fostering a culture of continuous improvement and vigilance, pharmaceutical companies can effectively safeguard public health and maintain trust in their products. This holistic approach underscores that delivering quality medicine is an ongoing commitment requiring coordinated efforts across the entire organization.

References

Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., Al Yami, M. S., Al Harbi, S., & Albekairy, A. M. (2023). Revolutionizing healthcare: The role of artificial intelligence in clinical practice. BMC Medical Education, 23(1), 689. https://doi.org/10.1186/s12909-023-04698-z

Arnold, D. G., Amato, L. H., Troyer, J. L., & Stewart, O. J. (2022). Innovation and misconduct in the pharmaceutical industry. Journal of Business Research, 144, 1052–1063. https://doi.org/10.1016/j.jbusres.2022.02.026

Barker Scott, B. A., & Manning, M. R. (2024). Designing the Collaborative Organization: A Framework for how Collaborative Work, Relationships, and Behaviors Generate Collaborative Capacity. The Journal of Applied Behavioral Science, 60(1), 149–193. https://doi.org/10.1177/00218863221106245

Dash, S., Shakyawar, S. K., Sharma, M., & Kaushik, S. (2019). Big data in healthcare: Management, analysis and future prospects. Journal of Big Data, 6(1), 54. https://doi.org/10.1186/s40537-019-0217-0

Dwivedi, Y. K., Kshetri, N., Hughes, L., Slade, E. L., Jeyaraj, A., Kar, A. K., Baabdullah, A. M., Koohang, A., Raghavan, V., Ahuja, M., Albanna, H., Albashrawi, M. A., Al-Busaidi, A. S., Balakrishnan, J., Barlette, Y., Basu, S., Bose, I., Brooks, L., Buhalis, D., … Wright, R. (2023). Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy. International Journal of Information Management, 71, 102642. https://doi.org/10.1016/j.ijinfomgt.2023.102642

Elendu, C., Amaechi, D. C., Okatta, A. U., Amaechi, E. C., Elendu, T. C., Ezeh, C. P., & Elendu, I. D. (2024). The impact of simulation-based training in medical education: A review. Medicine, 103(27), e38813. https://doi.org/10.1097/MD.0000000000038813

Haji, M., Kerbache, L., & Al-Ansari, T. (2022). Food Quality, Drug Safety, and Increasing Public Health Measures in Supply Chain Management. Processes, 10(9), 1715. https://doi.org/10.3390/pr10091715

Javaid, M., Haleem, A., Pratap Singh, R., & Suman, R. (2021). Significance of Quality 4.0 towards comprehensive enhancement in manufacturing sector. Sensors International, 2, 100109. https://doi.org/10.1016/j.sintl.2021.100109

Jones, C. H., & Dolsten, M. (2024). Healthcare on the brink: Navigating the challenges of an aging society in the United States. Npj Aging, 10(1), 22. https://doi.org/10.1038/s41514-024-00148-2

Katsoulakis, E., Wang, Q., Wu, H., Shahriyari, L., Fletcher, R., Liu, J., Achenie, L., Liu, H., Jackson, P., Xiao, Y., Syeda-Mahmood, T., Tuli, R., & Deng, J. (2024). Digital twins for health: A scoping review. Npj Digital Medicine, 7(1), 77. https://doi.org/10.1038/s41746-024-01073-0

Orazgaliyeva, E., Abuzhalitova, A., Sokhatskaya, N., Smykova, M., & Kazybayeva, A. (2024). Trust as a critical driver of customer loyalty in the pharmaceutical market: A study of Kazakhstan. Regional Science Policy & Practice, 16(9), 100021. https://doi.org/10.1016/j.rspp.2024.100021

Paul, M., Maglaras, L., Ferrag, M. A., & Almomani, I. (2023). Digitization of healthcare sector: A study on privacy and security concerns. ICT Express, 9(4), 571–588. https://doi.org/10.1016/j.icte.2023.02.007

Pertheban, T. R., Thurasamy, R., Marimuthu, A., Venkatachalam, K. R., Annamalah, S., Paraman, P., & Hoo, W. C. (2023). The Impact of Proactive Resilience Strategies on Organizational Performance: Role of Ambidextrous and Dynamic Capabilities of SMEs in Manufacturing Sector. Sustainability, 15(16), 12665. https://doi.org/10.3390/su151612665

Shojaei, P., Vlahu-Gjorgievska, E., & Chow, Y.-W. (2024). Security and Privacy of Technologies in Health Information Systems: A Systematic Literature Review. Computers, 13(2), 41. https://doi.org/10.3390/computers13020041

Simões, A., Veiga, F., & Vitorino, C. (2024). Question-based review for pharmaceutical development: An enhanced quality approach. European Journal of Pharmaceutics and Biopharmaceutics, 195, 114174. https://doi.org/10.1016/j.ejpb.2023.114174

Teangsompong, T., Yamapewan, P., & Sawangproh, W. (2024). Consumer trust in Thai street food vendors: Implications for the post-pandemic era. International Journal of Sociology and Social Policy, 44(13/14), 16–48. https://doi.org/10.1108/IJSSP-09-2023-0220

Torok, M., Sam, L., & Hebert, J. (2024). Translating a Culture of Quality to Clinical Research Conduct: Expanding the Clinical Development Quality Framework. Therapeutic Innovation & Regulatory Science, 58(3), 404–414. https://doi.org/10.1007/s43441-023-00610-5

Vassos, V., Voltezou, A., Stavropoulos, A., Stavropoulou, E., Stefanis, C., Tsigalou, C., Nena, E., Chatzaki, E., Constantinidis, T. C., & Bezirtzoglou, E. (2024). The Role of Total Quality Management in the Pharmaceutical, Food, and Nutritional Supplement Sectors. Foods, 13(16), 2606. https://doi.org/10.3390/foods13162606

Veríssimo, C., Pereira, L., Fernandes, A., & Martinho, R. (2024). Complex problem solving as a source of competitive advantage. Journal of Open Innovation: Technology, Market, and Complexity, 10(2), 100258. https://doi.org/10.1016/j.joitmc.2024.100258

Williamson, S. M., & Prybutok, V. (2024). Balancing Privacy and Progress: A Review of Privacy Challenges, Systemic Oversight, and Patient Perceptions in AI-Driven Healthcare. Applied Sciences, 14(2), 675. https://doi.org/10.3390/app14020675

Downloads

Published

2024-11-30

How to Cite

Ahmed, R. (2024). Ensuring Quality Medicine is not a Single Event but Rather Combines Effects of a Pharmaceutical Company. RADINKA JOURNAL OF HEALTH SCIENCE, 2(2), 226–241. https://doi.org/10.56778/rjhs.v2i2.360